INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 446m ago
House PTR45m ago
SEC 13F45m ago
Robinhood Chain45m ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
DS
dMY Squared Sponsor, LLCDirector, 10% Owner
DMYYdMY Squared Technology Group, Inc.
Derivative conversion
C—
1.16M sh
Mar 19, 2026
Page 1082 of 1737
← PrevNext →
Mar 20, 2026
traded Mar 19, 2026
+1d
SEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
506.3K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
126.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
21.2K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
506.3K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SP
Smith Robert Paul JRChief Commercial Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
572.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
375.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
126.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
638.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
562.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
9,167 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
440.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
9,699 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
487.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
100.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
162.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
HJ
Hyman JonathanChief Technology Officer
BRZEBraze, Inc.
Grant or award
A—
89.6K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
22.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
211.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
125.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
126.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
YL
You Harry L.Director, 10% Owner
HQHorizon Quantum Holdings Ltd.
Grant or award
A—
1.16M sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
125.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
18.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
NM
Neagle MatthewChief Operating Officer
PRCHPorch Group, Inc.
Option exercise
M—
826.6K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
487.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PS
Plaines StephanieDirector
COTYCOTY INC.
Grant or award
A—
7,142 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
BH
Brown HaydenDirector, President & CEO
UPWKUPWORK, INC
Option exercise
M—
28.7K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
MW
Magnuson WilliamDirector, Chief Executive Officer
BRZEBraze, Inc.
Grant or award
A—
293.9K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
572.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SP
Smith Robert Paul JRChief Commercial Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
562.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
WS
Wininger ShaiDirector, President
LMNDLemonade, Inc.
Grant or award
A—
180.0K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
32.3K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SR
Stewart John REVP - Chief Financial Officer
HBNCHORIZON BANCORP INC /IN/
Tax withholding
F$10K
643 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AM
AmundiDirector, 10% Owner
VCTRVictory Capital Holdings, Inc.
Disposition to issuer
D—
100.0K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
47.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

8
WJ
White Daniel JamesDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$8,448
266 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

5
BJ
Bevirt JoeBenDirector, CEO and Chief Architect
JOBYJoby Aviation, Inc.
Grant or award
A—
706.4K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

5
GE
Gessert EricaChief Financial Officer
UPWKUPWORK, INC
Option exercise
M—
8,433 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence